CEO Buys 550K Shares at $0.10—But 16% Dilution Casts Doubt on "Skin in the Game" Narrative

The headline is clear: CEO Evan Gappelberg bought 550,000 shares in November 2025 at an average price of $0.10. That's a $55,000 investment. His total post-purchase holdings now sit at 29,000,776 common shares. On paper, it looks like skin in the game. But the numbers tell a different story.

This purchase increased his stake by less than 2%. For a CEO already holding nearly 29 million shares, that's a minimal addition to a massive position. It's a rounding error in the grand scheme. More critically, it happened at a time when the company's own capital structure was moving in the opposite direction. Over the past year, total shares outstanding grew by 16.1%. That's dilution in action, directly reducing the ownership percentage of every existing shareholder, including the CEO's own stake.

So, what are we looking at? A CEO buying a tiny fraction of his own stock near a recent low, while the company's share count balloons. This is a classic case of a signal drowned out by the noise of dilution. The move doesn't override the larger trend of insider selling that often accompanies such capital raises. For the smart money, the real alignment of interest isn't measured in a single, small open-market buy. It's measured in whether insiders are net buyers or sellers, and whether they are fighting or benefiting from dilution. In this case, the CEO's purchase is a distraction, not a credible signal.

The Smart Money Trail: What Do Filings Show?

The filings tell a story of near-total inactivity. For the last three months, there have been no net insider purchases. In fact, the only reported insider transaction in the past two years was the CEO's single buy in November. That's it. No other officers, directors, or significant shareholders have bought or sold shares in that period. This isn't a pattern of accumulation; it's a vacuum.

The stock's recent move adds a layer of doubt. It fell 12.5% in the last day, closing at $0.1050. That sharp drop, happening just days after the CEO's purchase, raises a direct question: if the CEO is truly bullish, why didn't he buy more when the price was falling? The silence from other insiders is deafening. In a stock where the CEO's own stake is being diluted by a 16% increase in shares outstanding, the lack of any other buying is a red flag. It suggests the smart money isn't seeing value here, or at least isn't willing to commit capital.

Institutional activity is equally murky. Data on net institutional purchases is insufficient to determine if large funds are buying or selling recently. Without that clarity, we can't point to a whale wallet accumulating shares. The institutional picture is blank, leaving the field wide open for retail speculation.

The bottom line from the filings is stark. There is no evidence of a coordinated smart money move. The only significant transaction is a single, small CEO buy that now looks isolated and potentially out of step with the stock's recent weakness. When the filings show no net insider buying and no clear institutional accumulation, the signal is clear: the smart money is on the sidelines.

Catalysts and Risks: What to Watch

The weak signals from insider activity and dilution set a low bar. The real test comes from near-term events that will either confirm the skepticism or validate the CEO's bullish comments. The key watchpoints are straightforward: watch for insider sales, monitor the dilution rate, and demand proof of operational performance.

First, any significant insider sales in the coming quarters would directly contradict the CEO's stated optimism. His press release from November called the current share price a "mispricing" and expressed "extreme excitement" about the business prospects. If other insiders, particularly officers or directors, start selling while he is still buying, it would signal a dangerous divergence. The current vacuum of insider trading is a neutral signal; a sudden wave of sales would be a clear bearish warning.

Second, the dilution rate is a critical metric to monitor. The company's total shares outstanding grew by 16.1% over the past year. This isn't just a past event; it's an ongoing pressure that erodes the value of every existing share, including the CEO's new purchase. If the company continues to issue new shares to fund operations or raise capital, the CEO's skin in the game gets diluted further. The smart money will be watching the next few quarters for any new share issuances that could accelerate this erosion.

Finally, the fundamental catalyst is operational performance. Without revenue growth to justify the price, the stock lacks a floor. The CEO's optimism is a statement of belief, not a financial fact. The market will need to see concrete results-likely in the form of quarterly earnings reports-to determine if the "strong forward growth" he envisions is real. Until then, the stock remains a speculative bet on future execution, with the CEO's small buy serving as a faint, easily drowned-out signal.